Showing results (51-60 of 124) with videos related to
Sort By:
Pageof 13
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|October 20, 2015
Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirusShuya Yano, Shinji Miwa, Hiroyuki Kishimoto, et al.The Journal of Biological Chemistry|December 31, 2013
The nucleolar protein Myb-binding protein 1A (MYBBP1A) enhances p53 tetramerization and acetylation in response to nucleolar disruptionWakana Ono, Yuki Hayashi, Wataru Yokoyama, et al.Journal of Applied Crystallography|April 10, 2026
Spin-contrast-variation small-angle neutron scattering study of fully and partially swollen silica-filled rubberYohei Noda, Satoshi Koizumi, Tomomi Masui, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[A successful multimodality therapy for a case of recurrent rectal cancer with KRAS mutation]Ayako Watanabe, Ryo Inada, Takeshi Nagasaka, et al.Oncology Letters|February 14, 2018
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancerTatsuya Morikawa, Ryo Inada, Takeshi Nagasaka, et al.Acta Medica Okayama|April 23, 2015
Aggressive multimodality treatment for advanced rectal cancerRyo Inada, Takeshi Nagasaka, Toshiaki Toshima, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 7, 2015
[A case of appendix cancer treated as cancer of unknown primary origin]Hijiri Matsumoto, Ryo Inada, Takeshi Nagasaka, et al.International Journal of Cancer|February 16, 2006
Enhanced antitumor efficacy of telomerase-selective oncolytic adenoviral agent OBP-401 with docetaxel: preclinical evaluation of chemovirotherapyToshiya Fujiwara, Shunsuke Kagawa, Hiroyuki Kishimoto, et al.Oncotarget|October 1, 2016
Fluorescence-guided surgery of a highly-metastatic variant of human triple-negative breast cancer targeted with a cancer-specific GFP adenovirus prevents recurrenceShuya Yano, Kiyoto Takehara, Shinji Miwa, et al.Cell Cycle (Georgetown, Tex.)|January 6, 2017
Eradication of melanoma in vitro and in vivo via targeting with a Killer-Red-containing telomerase-dependent adenovirusKiyoto Takehara, Shuya Yano, Hiroshi Tazawa, et al.Pageof 13